Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:51:59 UTC |
---|
HMDB ID | HMDB0015438 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Spirapril |
---|
Description | Spirapril, also known as quadropril or renpress, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Spirapril is a very strong basic compound (based on its pKa). In humans, spirapril is involved in spirapril action pathway. Unlike other members of the group, it is eliminated both by renal and hepatic routes, which may allow for greater use in patients with renal impairment. However, data on its effect upon the renal function are conflicting. It belongs to dicarboxy group of ACE inhibitors. It was patented in 1980 and approved for medical use in 1995. Spirapril, sold under the brand name Renormax among others, is an ACE inhibitor antihypertensive drug used to treat hypertension. Like many ACE inhibitors, this prodrug is converted to the active metabolite spiraprilat following oral administration. |
---|
Structure | CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2 InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1 |
---|
Synonyms | Value | Source |
---|
Quadropril | HMDB | Renpress | HMDB | Spirapril hydrochloride | HMDB | Renormax | HMDB |
|
---|
Chemical Formula | C22H30N2O5S2 |
---|
Average Molecular Weight | 466.614 |
---|
Monoisotopic Molecular Weight | 466.15961346 |
---|
IUPAC Name | (8S)-7-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid |
---|
Traditional Name | spirapril |
---|
CAS Registry Number | 83647-97-6 |
---|
SMILES | CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2 |
---|
InChI Identifier | InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1 |
---|
InChI Key | HRWCVUIFMSZDJS-SZMVWBNQSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Dipeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-dipeptide
- Alpha-amino acid ester
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- N-acyl-l-alpha-amino acid
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- N-acylpyrrolidine
- Pyrrolidine carboxylic acid
- Pyrrolidine carboxylic acid or derivatives
- Fatty acid ester
- Aralkylamine
- Dithioketal
- Monocyclic benzene moiety
- Fatty acyl
- Dicarboxylic acid or derivatives
- Benzenoid
- Pyrrolidine
- Dithiolane
- Tertiary carboxylic acid amide
- Thioacetal
- 1,3-dithiolane
- Amino acid or derivatives
- Carboxylic acid ester
- Amino acid
- Carboxamide group
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid
- Secondary aliphatic amine
- Dialkylthioether
- Thioether
- Secondary amine
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Organopnictogen compound
- Amine
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.029 g/L | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Spirapril,1TMS,isomer #1 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O[Si](C)(C)C)SCCS2 | 3650.2 | Semi standard non polar | 33892256 | Spirapril,1TMS,isomer #2 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N([C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2)[Si](C)(C)C | 3642.4 | Semi standard non polar | 33892256 | Spirapril,2TMS,isomer #1 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N([C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O[Si](C)(C)C)SCCS2)[Si](C)(C)C | 3610.4 | Semi standard non polar | 33892256 | Spirapril,2TMS,isomer #1 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N([C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O[Si](C)(C)C)SCCS2)[Si](C)(C)C | 3358.3 | Standard non polar | 33892256 | Spirapril,2TMS,isomer #1 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N([C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O[Si](C)(C)C)SCCS2)[Si](C)(C)C | 4596.8 | Standard polar | 33892256 | Spirapril,1TBDMS,isomer #1 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)SCCS2 | 3842.1 | Semi standard non polar | 33892256 | Spirapril,1TBDMS,isomer #2 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N([C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2)[Si](C)(C)C(C)(C)C | 3834.6 | Semi standard non polar | 33892256 | Spirapril,2TBDMS,isomer #1 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N([C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)SCCS2)[Si](C)(C)C(C)(C)C | 3999.0 | Semi standard non polar | 33892256 | Spirapril,2TBDMS,isomer #1 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N([C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)SCCS2)[Si](C)(C)C(C)(C)C | 3765.2 | Standard non polar | 33892256 | Spirapril,2TBDMS,isomer #1 | CCOC(=O)[C@H](CCC1=CC=CC=C1)N([C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)SCCS2)[Si](C)(C)C(C)(C)C | 4703.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Spirapril GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-2329000000-e6426e1f4b1766007fb1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Spirapril GC-MS (1 TMS) - 70eV, Positive | splash10-014i-3020900000-bae90ea325c8ab017203 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Spirapril GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Spirapril GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 10V, Positive-QTOF | splash10-014i-0151900000-794ab140bd7377bee543 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 20V, Positive-QTOF | splash10-001i-2492200000-3e1605fcedb193a44513 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 40V, Positive-QTOF | splash10-08gu-3940000000-8cfd8a9e4db6203ffd42 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 10V, Negative-QTOF | splash10-052f-9001400000-c0d3ef34b28403d583fb | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 20V, Negative-QTOF | splash10-0a4i-9000000000-e68f2dc1894747d86885 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 40V, Negative-QTOF | splash10-0a4i-9101000000-99d2254d32243752bbac | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 10V, Positive-QTOF | splash10-014i-0021900000-9d3ec1b110ee9ea14e5f | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 20V, Positive-QTOF | splash10-00r6-0425900000-4de98c170e5f68982b37 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 40V, Positive-QTOF | splash10-014i-3920000000-554f8dbc645d0b1dd714 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 10V, Negative-QTOF | splash10-014i-0000900000-438d7bc3c320eca0298a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 20V, Negative-QTOF | splash10-014l-3135900000-a3b59b47cb7d860d17d6 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Spirapril 40V, Negative-QTOF | splash10-0nmi-3921000000-2906c69550f813e0c035 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - Rosendorff C, Patton J, Radford HM, Kalliatakis B: Alpha-adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor. J Cardiovasc Pharmacol. 1992;19 Suppl 6:S105-9. [PubMed:1382157 ]
- Hannedouche T, Ikeni A, Marques LP, Natov S, Dechaux M, Schmitt F, Lacour B, Grunfeld JP: Renal effects of angiotensin II in normotensive subjects on short-term cilazapril treatment. J Cardiovasc Pharmacol. 1992;19 Suppl 6:S25-7. [PubMed:1382161 ]
- Noble S, Sorkin EM: Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension. Drugs. 1995 May;49(5):750-66. [PubMed:7601014 ]
- Shohat J, Wittenberg C, Erman A, Rosenfeld J, Boner G: Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension. Scand J Urol Nephrol. 1999 Feb;33(1):57-62. [PubMed:10100366 ]
|
---|